Brain morphological changes associated with exposure to HSV1 in first-episode schizophrenia

K. M R Prasad, B. H. Shirts, Robert H Yolken, M. S. Keshavan, V. L. Nimgaonkar

Research output: Contribution to journalArticle

Abstract

Infectious agents have been proposed as one of the risk factors for schizophrenia. However, the data on the association of infectious agents with in vivo brain changes are scant. We evaluated the association of serological evidence of exposure to herpes simplex virus 1 (HSV1) with in vivo brain structural variations among first-episode antipsychotic-naive schizophrenia/schizoaffective disorder patients and control subjects. We assayed HSV1 immunoglobulin G (IgG) antibody in serum samples from 30 patients and 44 healthy subjects and obtained structural magnetic resonance imaging scans from the same individuals. There were proportionately more patients with elevated HSV1 antibody ratios than healthy comparison subjects (χ2=3.98, 1 df, P=0.046) and patients had significantly higher HSV1 IgG antibody ratios compared with healthy subjects. Using optimized voxel-based morphometry, we examined diagnosis by HSV1 serological status interaction followed by within- and between-group comparison across the serological status. We observed a diagnosis by HSV1 serological status interaction and a significant main effect of HSV1 serological status in the prefrontal gray matter. Patients exposed to HSV1 had decreased gray matter in Brodmann area 9 (dorsolateral prefrontal cortex) and 32 (anterior cingulate cortex) compared with patients without serological evidence of exposure to HSV1. HSV1-associated differences in brain structure were not detected among healthy subjects. These findings suggest that HSV1 exposure in schizophrenia is associated with specific regional gray matter differences that may not be attributable to medications, illness chronicity or comorbid substance use. This study provides suggestive evidence for a link between HSV1 exposure and some of the cerebral morphological changes often reported in schizophrenia.

Original languageEnglish (US)
Pages (from-to)105-113
Number of pages9
JournalMolecular Psychiatry
Volume12
Issue number1
DOIs
StatePublished - Jan 17 2007

Fingerprint

Human Herpesvirus 1
Schizophrenia
Brain
Healthy Volunteers
Antibodies
Immunoglobulin G
Gyrus Cinguli
Prefrontal Cortex
Psychotic Disorders
Antipsychotic Agents
Magnetic Resonance Imaging

Keywords

  • Etiology
  • Herpes simplex virus
  • Morphometry
  • Neuroanatomy
  • Neuroimaging
  • Schizophrenia

ASJC Scopus subject areas

  • Molecular Biology
  • Psychiatry and Mental health

Cite this

Brain morphological changes associated with exposure to HSV1 in first-episode schizophrenia. / Prasad, K. M R; Shirts, B. H.; Yolken, Robert H; Keshavan, M. S.; Nimgaonkar, V. L.

In: Molecular Psychiatry, Vol. 12, No. 1, 17.01.2007, p. 105-113.

Research output: Contribution to journalArticle

Prasad, K. M R ; Shirts, B. H. ; Yolken, Robert H ; Keshavan, M. S. ; Nimgaonkar, V. L. / Brain morphological changes associated with exposure to HSV1 in first-episode schizophrenia. In: Molecular Psychiatry. 2007 ; Vol. 12, No. 1. pp. 105-113.
@article{4dba908222db42de8506fab7a852cdad,
title = "Brain morphological changes associated with exposure to HSV1 in first-episode schizophrenia",
abstract = "Infectious agents have been proposed as one of the risk factors for schizophrenia. However, the data on the association of infectious agents with in vivo brain changes are scant. We evaluated the association of serological evidence of exposure to herpes simplex virus 1 (HSV1) with in vivo brain structural variations among first-episode antipsychotic-naive schizophrenia/schizoaffective disorder patients and control subjects. We assayed HSV1 immunoglobulin G (IgG) antibody in serum samples from 30 patients and 44 healthy subjects and obtained structural magnetic resonance imaging scans from the same individuals. There were proportionately more patients with elevated HSV1 antibody ratios than healthy comparison subjects (χ2=3.98, 1 df, P=0.046) and patients had significantly higher HSV1 IgG antibody ratios compared with healthy subjects. Using optimized voxel-based morphometry, we examined diagnosis by HSV1 serological status interaction followed by within- and between-group comparison across the serological status. We observed a diagnosis by HSV1 serological status interaction and a significant main effect of HSV1 serological status in the prefrontal gray matter. Patients exposed to HSV1 had decreased gray matter in Brodmann area 9 (dorsolateral prefrontal cortex) and 32 (anterior cingulate cortex) compared with patients without serological evidence of exposure to HSV1. HSV1-associated differences in brain structure were not detected among healthy subjects. These findings suggest that HSV1 exposure in schizophrenia is associated with specific regional gray matter differences that may not be attributable to medications, illness chronicity or comorbid substance use. This study provides suggestive evidence for a link between HSV1 exposure and some of the cerebral morphological changes often reported in schizophrenia.",
keywords = "Etiology, Herpes simplex virus, Morphometry, Neuroanatomy, Neuroimaging, Schizophrenia",
author = "Prasad, {K. M R} and Shirts, {B. H.} and Yolken, {Robert H} and Keshavan, {M. S.} and Nimgaonkar, {V. L.}",
year = "2007",
month = "1",
day = "17",
doi = "10.1038/sj.mp.4001915",
language = "English (US)",
volume = "12",
pages = "105--113",
journal = "Molecular Psychiatry",
issn = "1359-4184",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Brain morphological changes associated with exposure to HSV1 in first-episode schizophrenia

AU - Prasad, K. M R

AU - Shirts, B. H.

AU - Yolken, Robert H

AU - Keshavan, M. S.

AU - Nimgaonkar, V. L.

PY - 2007/1/17

Y1 - 2007/1/17

N2 - Infectious agents have been proposed as one of the risk factors for schizophrenia. However, the data on the association of infectious agents with in vivo brain changes are scant. We evaluated the association of serological evidence of exposure to herpes simplex virus 1 (HSV1) with in vivo brain structural variations among first-episode antipsychotic-naive schizophrenia/schizoaffective disorder patients and control subjects. We assayed HSV1 immunoglobulin G (IgG) antibody in serum samples from 30 patients and 44 healthy subjects and obtained structural magnetic resonance imaging scans from the same individuals. There were proportionately more patients with elevated HSV1 antibody ratios than healthy comparison subjects (χ2=3.98, 1 df, P=0.046) and patients had significantly higher HSV1 IgG antibody ratios compared with healthy subjects. Using optimized voxel-based morphometry, we examined diagnosis by HSV1 serological status interaction followed by within- and between-group comparison across the serological status. We observed a diagnosis by HSV1 serological status interaction and a significant main effect of HSV1 serological status in the prefrontal gray matter. Patients exposed to HSV1 had decreased gray matter in Brodmann area 9 (dorsolateral prefrontal cortex) and 32 (anterior cingulate cortex) compared with patients without serological evidence of exposure to HSV1. HSV1-associated differences in brain structure were not detected among healthy subjects. These findings suggest that HSV1 exposure in schizophrenia is associated with specific regional gray matter differences that may not be attributable to medications, illness chronicity or comorbid substance use. This study provides suggestive evidence for a link between HSV1 exposure and some of the cerebral morphological changes often reported in schizophrenia.

AB - Infectious agents have been proposed as one of the risk factors for schizophrenia. However, the data on the association of infectious agents with in vivo brain changes are scant. We evaluated the association of serological evidence of exposure to herpes simplex virus 1 (HSV1) with in vivo brain structural variations among first-episode antipsychotic-naive schizophrenia/schizoaffective disorder patients and control subjects. We assayed HSV1 immunoglobulin G (IgG) antibody in serum samples from 30 patients and 44 healthy subjects and obtained structural magnetic resonance imaging scans from the same individuals. There were proportionately more patients with elevated HSV1 antibody ratios than healthy comparison subjects (χ2=3.98, 1 df, P=0.046) and patients had significantly higher HSV1 IgG antibody ratios compared with healthy subjects. Using optimized voxel-based morphometry, we examined diagnosis by HSV1 serological status interaction followed by within- and between-group comparison across the serological status. We observed a diagnosis by HSV1 serological status interaction and a significant main effect of HSV1 serological status in the prefrontal gray matter. Patients exposed to HSV1 had decreased gray matter in Brodmann area 9 (dorsolateral prefrontal cortex) and 32 (anterior cingulate cortex) compared with patients without serological evidence of exposure to HSV1. HSV1-associated differences in brain structure were not detected among healthy subjects. These findings suggest that HSV1 exposure in schizophrenia is associated with specific regional gray matter differences that may not be attributable to medications, illness chronicity or comorbid substance use. This study provides suggestive evidence for a link between HSV1 exposure and some of the cerebral morphological changes often reported in schizophrenia.

KW - Etiology

KW - Herpes simplex virus

KW - Morphometry

KW - Neuroanatomy

KW - Neuroimaging

KW - Schizophrenia

UR - http://www.scopus.com/inward/record.url?scp=33845747224&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845747224&partnerID=8YFLogxK

U2 - 10.1038/sj.mp.4001915

DO - 10.1038/sj.mp.4001915

M3 - Article

C2 - 17033628

AN - SCOPUS:33845747224

VL - 12

SP - 105

EP - 113

JO - Molecular Psychiatry

JF - Molecular Psychiatry

SN - 1359-4184

IS - 1

ER -